These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11477137)

  • 21. Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.
    Trojan A; Lone YC; Briceno I; Trojan J
    Curr Med Chem; 2024; 31(15):1983-2002. PubMed ID: 38031775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression.
    Wang ZH; Ma J; Zeng BJ; Catanese VM; Samuels S; Gama Sosa MA; Kolodny EH
    Neuroendocrinology; 1997 Sep; 66(3):203-11. PubMed ID: 9380278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cells.
    Trabado S; Nguyen Van Binh P; Martin C; Lafarge-Frayssinet C; Thevenin M; Baudouin F; Warnet JM; Duc HT
    Biomed Pharmacother; 2006 Dec; 60(10):693-7. PubMed ID: 17071049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
    Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
    Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells.
    Yang JM; Chen WS; Liu ZP; Luo YH; Liu WW
    J Gastroenterol Hepatol; 2003 Mar; 18(3):296-301. PubMed ID: 12603530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model.
    Beutler AS; Banck MS; Wedekind D; Hedrich HJ
    Hum Gene Ther; 1999 Jan; 10(1):95-101. PubMed ID: 10022534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].
    Kang CS; Pu PY; Wang GX; Li YH; Dong L; Wang H
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1503-8. PubMed ID: 15500708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.
    Lafarge-Frayssinet C; Martin C; Van Binh PN; Achard-Ellouk S; Duc HT; Frayssinet C; Cardoso G; Desauty G; Warnet JM; Bréchot C; Sarasin A
    Anticancer Res; 2002; 22(6C):3895-904. PubMed ID: 12553010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of antisense VEGF gene on the growth of glioma cells BT325].
    Sun L; Lu J; Gong W; Liu Y; Han F; Wang Q; Zhang S; Huang Z
    Wei Sheng Yan Jiu; 2015 May; 44(3):413-6. PubMed ID: 26137620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
    Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
    Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
    Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.
    Shapiro DN; Jones BG; Shapiro LH; Dias P; Houghton PJ
    J Clin Invest; 1994 Sep; 94(3):1235-42. PubMed ID: 8083365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo.
    Pu P; Liu X; Liu A; Cui J; Zhang Y
    J Neurosurg; 2000 Jan; 92(1):132-9. PubMed ID: 10616092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.
    Yin D; Tamaki N; Parent AD; Zhang JH
    Neurol Res; 2005 Jan; 27(1):27-35. PubMed ID: 15829155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours.
    Trojan J; Pan YX; Wei MX; Ly A; Shevelev A; Bierwagen M; Ardourel MY; Trojan LA; Alvarez A; Andres C; Noguera MC; Briceno I; Aristizabal BH; Kasprzak H; Duc HT; Anthony DD
    Chemother Res Pract; 2012; 2012():721873. PubMed ID: 22400112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of anchorage-independent growth of human glioblastoma cell by major histocompatibility complex class I gene-transfection.
    Momozaki N; Oh-Uchida M; Tabuchi K; Ikezaki K; Hori K
    J Neurosurg; 1992 May; 76(5):845-9. PubMed ID: 1564545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of MHC class-1 antigen on rat glioma cells to cytokines.
    Oshiro S; Fukushima T; Tomonaga M; Black KL
    Anticancer Res; 2000; 20(1C):605-10. PubMed ID: 10769703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7-homolog 1 expression by human glioma: a new mechanism of immune evasion.
    Wilmotte R; Burkhardt K; Kindler V; Belkouch MC; Dussex G; Tribolet Nd; Walker PR; Dietrich PY
    Neuroreport; 2005 Jul; 16(10):1081-5. PubMed ID: 15973152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.
    Singh P; Dai B; Dhruva B; Widen SG
    Cancer Res; 1994 Dec; 54(24):6563-70. PubMed ID: 7527300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.